Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 April 2026 - 12:45

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/perjeta

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters